Polmacoxib (Synonyms: CG100649)
目录号: PL04655 纯度: ≥99%
CAS No. :301692-76-2
商品编号 规格 价格 会员价 是否有货 数量
PL04655-5mg 5mg ¥2472.73 请登录
PL04655-10mg 10mg ¥4327.27 请登录
PL04655-25mg 25mg ¥8407.27 请登录
PL04655-50mg 50mg 询价 询价
PL04655-100mg 100mg 询价 询价
PL04655-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2720.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Polmacoxib
中文别名
帕马考昔
英文名称
Polmacoxib
英文别名
4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide;5-{4-(aminosulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone;4-[3-(3-Fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl]benzenesulfonamide;Acelex;CG 100649;Polmacoxib
Cas No.
301692-76-2
分子式
C18H16NO4FS
分子量
361.39
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Polmacoxib (CG100649) 是一种首创的,具有口服活性的非甾体抗炎药 (NSAID),它是一种双重抑制剂,可以抑制 COX-2 (IC50 ~ 0.1 μg/ml)和碳酸酐酶 (carbonic anhydrase)。Polmacoxib 在小鼠模型中抑制大肠腺瘤和肿瘤生长。
生物活性
Polmacoxib (CG100649) is a first-in-class, orally active nonsteroidal anti-inflammatory drug (NSAID) which is a dual inhibitor of COX-2 (IC 50 around 0.1 μg/ml) and carbonic anhydrase. Polmacoxib inhibits colorectal adenoma and tumor growth in mouse models.
性状
Solid
IC50 & Target[1][2]
COX-2 0.1 μg/mL (IC50) carbonic anhydrase pan>&nbs
体外研究(In Vitro)
Polmacoxib (CG100649) (0-1 μg/ml; 24 hours; HCA-7 and HT-29 cells) can inhibit COX-2 activity and PGE2 production in human colon cancer cells, at lower concentrations compared to Celecoxib. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Polmacoxib (7 mg/kg; p.o.; daily for 8 weeks) suppresses intestinal polyp formation in Apc mice.
Polmacoxib (7-15 mg/kg; p.o.; daily from day 27 post-injection to day 111; athymic nude mice; subcutaneous xenograft mouse model) reduces tumor volume and tumor weight by 58% and 48%, respectively, compared to a 48% and 36% reduction following treatment with Celecoxib.
Polmacoxib (7-15 mg/kg; p.o.; began on day 14 and continued for 8 weeks; athymic nu/nu mice; orthotopic xenograft mouse model) inhibits CRC growth in an orthotopic xenograft mouse model, reducing tumor weight by 70% using 7 mg/kg or by 83% using 15 mg/kg, compared to a similar 70% reduction following treatment with 500 mg/kg of Celecoxib. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Kim SH, et al. CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models. Invest New Drugs. 2014;32(6):1105-1112.
[2]. Flick AC, et al. Synthetic Approaches to the New Drugs Approved During 2015 [published correction appears in J Med Chem. 2017 Oct 26;60(20):8680]. J Med Chem. 2017;60(15):6480-6515.
溶解度数据
In Vitro: DMSO : 250 mg/mL (691.77 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2